Details for 2018821303
Up to date per 01.04.2026
Actions
Details for 2018821303
Granted/Registered
European Patent
29.04.2020 A
03.11.2021 B1
21.06.2017
KR
20170078745
C07D 207/36 20060101AFI20201103BHEP
Owner
Daewoong Pharmaceutical Co., Ltd.35-14, Jeyakgongdan 4-gil Hyangnam-eup Hwaseong-si, Gyenoggi-do 18623KR
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
SHIN, Jeong-Taek Yongin-si Gyeonggi-do 16973KR
SON, Jeong Hyun Yongin-si Gyeonggi-do 17149KR
LEE, Seung Chul Suwon-si Gyeonggi-do 16224KR
Information about Fees